HIV sufferers benefit from the FDA’s unapproved drugs initiative

by Gary Puckrein, PhD

Unapproved drugs have never been tested by the Food and Drugs Administration for safety and efficacy. Prescribed by the million every year in the United States, these products pose a potential danger to all patients, but HIV/AIDS patients who suffer weakened immune systems are at an even higher risk as they are more vulnerable to injury due to their disease.

That’s why we …

Read more…

HIV sufferers benefit from the FDA’s unapproved drugs initiative

ADVERTISEMENT

1562
pages